ArticleEcoHealth2019
Field Diagnostics and Seasonality of Ophidiomyces ophiodiicola in Wild Snake Populations.
Article in EcoHealth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Article
- Ophidiomycosis Prevalence and Disease Ecology in a Natrix tessellata (Laurenti, 1768) Population From Northern Italy.Journal of experimental zoology. Part A, Ecological and integrative physiology · 2026Article
- Preliminary Screening forMicroorganisms · 2026Article
- Health assessment and multipathogen surveillance of free-ranging snakes in the southeastern United States.Frontiers in veterinary science · 2026Article
- An emergent disease reduces survival of mature female eastern diamondback rattlesnakes (Crotalus adamanteus), a key demographic for a slow-lived species.Scientific reports · 2025Article
- Effects of snake fungal disease (ophidiomycosis) on the skin microbiome across two major experimental scales.Conservation biology : the journal of the Society for Conservation Biology · 2025Article
- Snake Fungal Disease (Ophidiomycosis) in Northern Pine Snakes (Journal of fungi (Basel, Switzerland) · 2025Article
- Nationwide Screening Unveils EndemicJournal of fungi (Basel, Switzerland) · 2025Article
- Contribution of host species and pathogen clade to snake fungal disease hotspots in Europe.Communications biology · 2024Article
- Characterisation, prevalence and severity of skin lesions caused by ophidiomycosis in a population of wild snakes.Scientific reports · 2024Article
- Effects of ophidiomycosis on movement, survival, and reproduction of eastern foxsnakes (Pantherophis vulpinus).Scientific reports · 2024Article
- Snake Fungal Disease in Free-Ranging Northern Pine Snakes (Journal of fungi (Basel, Switzerland) · 2024Article
- Pilot survey reveals ophidiomycosis in dice snakes Natrix tessellata from Lake Garda, Italy.Veterinary research communications · 2023Article
- A Cross-Inoculation Experiment Reveals thatApplied and environmental microbiology · 2023Article
- Leveraging preserved specimens ofEcology and evolution · 2023Article
- Major Emerging Fungal Diseases of Reptiles and Amphibians.Pathogens (Basel, Switzerland) · 2023Review
- Article
- Incidents of snake fungal disease caused by the fungal pathogenFrontiers in fungal biology · 2023Article
- Comparative host-pathogen associations of Snake Fungal Disease in sympatric species of water snakes (Nerodia).Scientific reports · 2022Article
- The population genetics of the causative agent of snake fungal disease indicate recent introductions to the USA.PLoS biology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Snake fungal disease (SFD) is an emerging disease caused by the fungal pathogen, Ophidiomyces ophiodiicola. Clinical signs of SFD include dermal lesions, including regional and local edema, crusts, and ulcers. Snake fungal disease is widespread in the Eastern United States, yet there are limited data on how clinical signs of SFD compare with laboratory diagnostics. We compared two sampling methods for O. ophiodiicola, scale clip collection and swabbing, to evaluate whether collection method impacted the results of polymerase chain reaction (PCR). In addition, we evaluated the use of clinical signs to predict the presence of O. ophiodiicola across seasons, snake habitat affiliation (aquatic or terrestrial) and study sites. We found no significant difference in PCR results between sampling methods. Clinical signs were a strong predictor of O. ophiodiicola presence in spring and summer seasons. Snakes occupying terrestrial environments had a lower overall probability of testing positive for O. ophiodiicola compared to snakes occupying aquatic environments. Although our study indicates that both clinical signs of SFD and prevalence of O. ophiodiicola vary seasonally and based on habitat preferences of the host, our analysis suggests that clinical signs can serve as a reliable indicator of O. ophiodiicola presence, especially during spring and summer.
Indexed as
Identifiers
30349999What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.